Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Abstract excerpt

We present an integrated analysis of the clinical measurements, immune cells, and plasma multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial blood draws collected during the first week of infection following diagnosis. We identify a major shift between mild and moderate disease, at which point elevated inflammatory signaling is accompanied by the loss of specific classes...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to COVID-19 Clinical Research Studies
• Share to Diabetes and associated disorders
• Share to Single-cell and spatial transcriptomics